Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (261-270 of 341) with videos related to

Pageof 35
Sort By:
Journal of Clinical Medicine|February 24, 2019
Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic ReviewKwang Seob Lee, Andreas Kronbichler, Daniel Fernando Pereira Vasconcelos, et al.
Autoimmunity Reviews|October 29, 2011
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohortsCándido Díaz-Lagares, Sara Croca, Shirish Sangle, et al.
Rheumatology (Oxford, England)|January 26, 2024
IgA vasculitis nephritis-outcomes in adult-onset diseaseJames Stanway, Nina Brown, Afeera Pervez, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2017
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)Federica Maritati, Roberta Fenoglio, Evangeline Pillebout, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre StudyAglaia Chalkia, Marusa Kotnik, Timothy J Sadler, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
Rheumatology (Oxford, England)|September 22, 2018
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
Pageof 35

Showing results (261-270 of 341) with videos related to

Sort By:
Pageof 35
Journal of Clinical Medicine|February 24, 2019
Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic ReviewKwang Seob Lee, Andreas Kronbichler, Daniel Fernando Pereira Vasconcelos, et al.
Autoimmunity Reviews|October 29, 2011
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohortsCándido Díaz-Lagares, Sara Croca, Shirish Sangle, et al.
Rheumatology (Oxford, England)|January 26, 2024
IgA vasculitis nephritis-outcomes in adult-onset diseaseJames Stanway, Nina Brown, Afeera Pervez, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
Annals of the Rheumatic Diseases|December 1, 2011
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-upLorraine Harper, Matthew D Morgan, Michael Walsh, et al.
BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2017
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)Federica Maritati, Roberta Fenoglio, Evangeline Pillebout, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre StudyAglaia Chalkia, Marusa Kotnik, Timothy J Sadler, et al.
Annals of the Rheumatic Diseases|August 26, 2010
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexRavi Suppiah, Oliver Flossman, Chetan Mukhtyar, et al.
Rheumatology (Oxford, England)|September 22, 2018
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisRuth J Pepper, Stephen P McAdoo, Sarah M Moran, et al.
Pageof 35